Patent No. United States 06/793,980 Australia 65981/86 Issued 606,320 Canada 521,909 Abandoned Denmark 3385/87 Pending Taiwan 75105650 Issued 51922 *United States U.S. National Phase of PCT/US86/02269
Appears in 6 contracts
Samples: Product Sublicense Agreement, Product Sublicense Agreement (Immune Pharmaceuticals Inc), License Agreement (Xoma LTD /De/)
